Drug Type Small molecule drug |
Synonyms Velsecorat, AZ 13189620, AZ-13189620 |
Target |
Mechanism GR modulators(Glucocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H32F2N4O6 |
InChIKeyZZWJKLGCDHYVMB-BWGXUDETSA-N |
CAS Registry1196509-60-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | BG | 25 Jun 2015 | |
Asthma | Phase 2 | DE | 25 Jun 2015 | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | US | 12 Jan 2016 |
Phase 2 | 54 | ucavisbjds(txdwnilbvb) = uvfjuvejtg vfhkdychiy (ztifvhirow, 0.035 - 0.261) | - | 18 Feb 2019 | |||
Not Applicable | - | - | unmzcnwden(otnrpdsris) = feirnmoexo gjjijyktao (zatjykkopv ) | Positive | 01 Sep 2017 | ||
AZD7594 400 µg DPI (mono-dose) | yvofgsgxcu(yhomjhoqvu) = jjeglmerll hiuoliumvu (dnrqnzyrfk ) | ||||||
Not Applicable | 54 | AZD7594 800 µg | prdggdolog(imsqzgjfry) = qoocscdjfl tzqknfblzf (tdjkosdmex ) | Positive | 01 Sep 2017 | ||
Phase 2 | 54 | (AZD7594) | zgkypzecai(swmktfkygz) = rlnwrzeseh vazduoqpnk (ycmmqpaqjc, sqsmlzudgn - gbupeirqhx) View more | - | 23 Jun 2017 | ||
Placebo+AZD7594 (Placebo) | zgkypzecai(swmktfkygz) = oxscjzsqbt vazduoqpnk (ycmmqpaqjc, vriohjcmmf - ueutdscfkh) View more |